Pidilite Industries shares rose 0.93% to Rs 1,473.70 on Friday after the company appointed Amit Agarwal as CFO-designate. Agarwal brings over 22 years of finance experience to the firm. He previously worked with Pfizer, Hindustan Unilever, and Vedanta Resources. The board approved his new role effective from October 9, 2026.

Pidilite Industries shares rose on Friday after the company appointed Amit Agarwal as CFO-designate and Senior Management Personnel, effective October 9, 2026. Agarwal brings over 22 years of finance experience and has previously worked with Pfizer, Hindustan Unilever and Vedanta Resources. He is a Chartered Accountant, Cost Accountant and Company Secretary.

Shares of Pidilite Industries rose 0.93% to Rs 1,473.70 on Friday, after the company announced the appointment of Amit Agarwal as Chief Financial Officer-designate (CFO-designate) and Senior Management Personnel, effective October 9, 2026.

The appointment was approved by the company's board through a circular resolution passed on Friday, following a recommendation from the Nomination and Remuneration Committee. The company confirmed the news in a filing to the exchanges.

Who is Amit Agarwal?Amit Agarwal brings more than 22 years of experience in finance functions, including accounting, reporting, audit and control, the filing mentioned.

Agarwal has worked with several established companies, including Pfizer Limited, Hindustan Unilever Limited and Vedanta Resources Limited.

His experience spans key finance functions, including financial reporting, accounting, audit and control, areas that form an important part of a company's financial management and reporting processes.

He is a Chartered Accountant, Cost Accountant and Company Secretary, bringing professional qualifications across accounting, cost management and corporate compliance.

Pidilite did not provide further details in the filing on the transition timeline for the CFO-designate role or any changes to its existing finance leadership structure.

The company disclosed the appointment on October 9, 2026, following the board's approval of Agarwal's appointment as CFO-designate and Senior Management Personnel with effect from the same date.